|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Incidence and mortality of esophagus cancer in China, 2008-2012显示文摘Objective: To analyze the incidence and mortality rates of esophagus cancer in China from 2008 to 2012.Methods: Incident and mortality cases of esophagus cancer were retrieved from the National Central Cancer Registry(NCCR) database collecting from 135 cancer registries in China during 2008-2012. The incidence and mortality rates of esophagus cancer were calculated by area(urban/rural), region(eastern, middle, western), gender and age group(0, 1-4, 5-84 by 5 years and 85+ years). China census in 2000 and Segi’s world population were applied for age-standardized rates. Joinpoint model was used for time-trend analysis.Results: The crude incidence rate of esophagus cancer was 22.57/100,000. The age-standardized incidence rates by China standard population(ASIRC) and by world standard population(ASIRW) were 14.58/100,000 and14.80/100,000, respectively. The crude mortality rate of esophagus cancer was 17.19/100,000. The agestandardized mortality rates by Chinese standard population(ASMRC) and by world standard population(ASMRW) were 10.80/100,000 and 10.86/100,000 respectively. Incidence and mortality rates of esophagus cancer were higher in males than in females and higher in rural areas than in urban areas. The crude incidence rate in middle areas was the highest among all areas, followed by western areas and eastern areas. The age-specific incidence rate of esophagus cancer was relatively low in age groups before 40 years old and then increased after 45 years old. It peaked in the age group of 80-84 years. The patterns of age-specific mortality rates of esophagus cancer were close to those of age-specific incidence rates. The ASIRC of esophagus cancer decreased dramatically by 29.87% between 2003 and 2012, from 14.33/100,000 to 10.05/100,000. The esophagus cancer incidence rate decreased by 3.76% per year(P>0.05). The mortality rate of esophagus cancer decreased annually over the decades from 2003 to 2012 in China(P>0.05). In females, the annual percentage change(APC) of mortality rate was-5.43%[95% confidence intervals(95% CI):-6.50%,-4.30%](P<0.05) and the mortality rate of esophagus cancer in rural females was statistically significant(APC:-3.20%, 95% CI:-4.20%,-2.20%)(P<0.05).Conclusions: The focus of prevention and treatment for esophagus cancer is strengthening primary prevention of esophageal cancer, and promoting esophagus cancer secondary prevention to reduce incidence and mortality rates of esophagus cancer, prolong survival rate of patients and decline the burden of esophagus cancer in China. | Yutong He Daojuan Li Baoen Shan Di Liang Jin Shi Wanqing Chen Jie He | 2019 | Chinese Journal of Cancer Research2019，31，3： | 24 |
| 2 | Incidence and mortality rate of esophageal cancer has decreased during past 40 years in Hebei Province,China显示文摘Background:Hebei province is located in North of China with of approximately 6% of whole national population.It is known as a high-risk area for esophageal cancer in China and worldwide.The aim of our study was to estimate the esophageal cancer burden and trend in Hebei Province.Methods:Eight cancer registries in Hebei Province submitted cancer registry data to the Hebei Provincial Cancer Registry Center.All data were qualified and compiled for cancer statistics in 2011.The pooled data were stratified by gender and age group(0,1-4,5-9,10-14…80+).Incidence and mortality rates were age-standardized to World Segi's population standard and expressed per 100,000 persons.In addition,proportions and cumulative incidence/mortality rates for esophageal cancer were calculated.Esophageal cancer mortality data during the periods 1973-1975,1990-1992,and 2004-2005 were extracted from the national death surveys.Mortality and incidence rate data from Cixian and Shexian were obtained from population-based cancer registries in each county.Results:The estimated number of newly diagnosed esophageal cancer cases and deaths in 2011 in Hebei Province was 24,318 and 18,226,respectively.The crude incidence rate of esophageal cancer was 33.37/100,000(males,42.18/100,000 and females,24.31/100,000).The age-standardized rate by world standard population(ASRW) was 28.09/100,000,ranking third among all cancers.The esophageal cancer mortality rate was 25.01/100,000(males,31.40/100,000 and females,18.45/100,000),ranking third in deaths among all cancers.The mortality rates of esophageal cancer displayed a significant decreasing trend in Hebei Province from 1973-1975(ASRW =48.69/100,000) to 2004-2005(ASRW =28.02/100,000),with a decreased rate of 42.45%.In Cixian,the incidence of esophageal cancer decreased from 250.76/100,000 to 106.74/100,000 in males and from 153.86/100,000 to 75.41/100,000 in females,with annual percentage changes(APC) of 2.13 and 2.16,while the mortality rates declined with an APC of 2.46 for males and 3.10 for females from 1988 to 2011.In Shexian,the incidence rate decreased from 116.90/100,000 to 74.12/100,000 in males and from 46.98/100,000 to 40.64/100,000 in females,while the mortality rates declined,with an APC of 4.89 in males from 2003 to 2011.Conclusions:Although the incidence and mortality rates of esophageal cancer remain high,an obvious decreasing trend has been observed in Hebei Province,as well as in high-risk regions,such as Cixian and Shexian,over the past 40 years. | Yutong He Yan Wu Guohui Song Yongwei Li Di Liang Jing Jin Denggui Wen Baoen Shan | 2015 | Chinese Journal of Cancer Research2015，27，6： | 22 |
| 3 | Antitumor Activity and Immune Enhancement of Murine Interleukin-23 Expressed in Murine Colon Carcinoma Cells显示文摘cytokine p19 和 IL-12 的 p40 子单元填写了的 Interleukin (IL )-23, ,能从激活的 T 房间提高记忆 T 房间和 IFN- 的生产的增长。它能也在鼠科的模型导致 antitumor 效果。为了推进,在 vivo 评估 antitumor 活动和 IL-23 的有免疫力的改进,鼠科的结肠癌房间 retrovirally,有 mIL-23 基因的 transduced 皮下地被注射(s.c ) 进 BALB/c mice.Survival,时间和肿瘤体积被观察。LDH 版本试金,[3H ]-TdR 加入试金和 ELISA 被用来决定 CTL 活动, splenocytes 的增长和 cytokines 的水平分别地。树枝状的房间(DC ) 的数字被流动 cytometry (FCM ) 分析。Colon26/IL-23 房间分泌的 IL-23 压制了肿瘤的生长并且延长了老鼠, splenocytes 的提高的增长, CTL 活动,和 DC 的数字的幸存时间。IL-23 也支持了象 IFN- , IL-12 和 TNF-o 那样的 Th1 cytokines 的生产。然而, IL-4 的水平没显著地被提高。这些数据建议肿瘤房间分泌的 IL-23 能由提高有免疫力的反应导致 antitumor 活动。 | Baoen Shan Jingsheng Hao Qiaoxia Li Masatoshi Tagawa | 2006 | Cellular & Molecular Immunology2006，3，1： | 11 |
| 4 | Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China显示文摘Objective:This study aimed to investigate the potential determining epidemiological and clinical risk factors affecting the survival of esophageal cancer(EC)patients across multiple hospitals in China.Methods:This was a multicenter study comprising of newly diagnosed EC cases from Beijing,Hebei,Henan,Hubei,Zhejiang,and Guangdong Province of China.Their baseline characteristics and treatment methods data were collected from their medical records.The EpiData software was used for data quality control.The Kaplan-Meier method was used to estimate their overall survival(OS),and the Cox’s proportional hazard regression model was used to estimate hazard ratios(HR)and 95%confidence interval(CI).Results:The 3-and 5-year OS rates of the 5283 investigated EC patients were 49.98%and 39.07%,respectively.Their median survival was 36.00 months.The median survival time of females was longer than that of males(females vs.males:45.00 vs.33.00,P<0.001).The 5-year OS rate of patients who never-smoked was higher than that of smokers(never-smokers vs smokers:40.73%vs.37.84%,P=0.001).There was no significant difference in the 5-year OS rate between drinkers and never-drinkers(drinkers vs never-drinkers:34.22%vs.29.65%,P=0.330).In multivariate analysis,pathological stage(stage II:HR=1.80,95%CI=1.40-2.31;stage III:HR=2.62,95%CI=2.06-3.34;stage IV:HR=3.90,95%CI=2.98-5.09),poor differentiation/undifferentiated(HR=1.34,95%CI=1.11-1.63),not married status(HR=2.45,95%CI=1.49-4.04),production and service personnel(HR=1.36,95%CI=1.01-1.83)and farming/fishing(HR=1.40,95%CI=1.12-1.76)were independent prognostic risk factors for poor EC survival.Tumors in the thoracic or abdominal part of the esophagus,female and family history of any cancer were independent factors predictive of a good EC OS.Conclusion:Gender,marital status,occupation,family history of any cancer,tumor topographical site,differentiation status,and pathological stage were associated with the survival rate of EC.This study reveals important clinical characteristics of esophageal cancer patients in China and provides helpful information for their clinical management and surveillance. | Yutong He Di Liang Lingbin Du Tiantian Guo Yanyu Liu Xibin Sun Ning Wang Min Zhang Kuangrong Wei Baoen Shan Wanqing Chen | 2020 | Cancer Communications2020，40，10： | 8 |
| 5 | Estimated cancer incidence and mortality in Hebei province,2012显示文摘Objective: This study estimates the numbers of new cancer cases and cancer deaths in Hebei province using incidence and mortality data from 9 population-based cancer registries in 2012.Methods: The data of new diagnosed cancer cases and cancer deaths in 2012 were collected from 9 population-based cancer registries of Hebei province in 2015. All the data met the National Central Cancer Registry of China(NCCR) criteria of data quality. The pooled data analysis was stratified by areas(urban/rural), gender, age group(0, 1-4, 5-9, 10-14, …, 85+) and cancer type. New cancer cases and deaths in Hebei province were estimated using age-specific rates and corresponding provincial population in 2012. The 10 most common cancers in different groups and the cumulative rates were calculated. Chinese population census in 2000 and Segi's population were used for age-standardized incidence/mortality rates. Results: All cancer registries covered 4,986,847 populations, 6.84% of Hebei provincial population(2,098,547 in urban and 2,888,300 in rural areas). The percentage of cases morphologically verified(MV%) and death certificate-only cases(DCO%) were 76.40% and 4.72%, respectively. The mortality to incidence rate ratio(M/I) was 0.64. In 2012, it is estimated that there were about 187,900 new diagnosed cancer cases and 119,800 cancer deaths in Hebei province. The incidence rate of cancer was 258.12/100,000(275.75/100,000 in males, 239.78/100,000 in females), and the age-standardized incidence rates by Chinese standard population(ASIRC) and by world standard population(ASIRW) were 210.65/100,000 and 208.50/100,000, with the cumulative incidence rates(0-74 years old) of 24.46%. The cancer incidence and ASIRC were 256.99/100,000 and 211.32/100,000 in urban areas and 258.94/100,000 and 209.99/100,000 in rural areas, respectively. The cancer mortality rate was 164.63/100,000(201.85/100,000 in males, 125.92/100,000 in females). Agestandardized mortality rates by Chinese standard population(ASMRC) and by world standard population(ASMRW) were 137.30/100,000 and 137.39/100,000 with the cumulative mortality rate(0-74 years old) of 14.58%, respectively. The cancer mortality rate in rural areas(167.16/100,000) was higher than that in urban areas(161.16/100,000). The most common cancers were lung cancer, stomach cancer, breast cancer, esophageal cancer, liver cancer and colorectal cancer, which accounted for 72.31% of all cancer cases. Lung cancer, stomach cancer, liver cancer, esophageal cancer and colorectal cancer were the major causes of cancer death in Hebei province, which accounted for 75.24% of all cancer deaths. The cancer spectrum differs between urban and rural, males and females in both incidence and mortality rates.Conclusions: The most common cancers were lung cancer, stomach cancer, esophageal cancer, breast cancer, liver cancer and colorectal cancer in Hebei province. | Yutong He Di Liang Daojuan Li Jingbo Zhai Junqing Zhu Jing Jin Denggui Wen Baoen Shan | 2016 | Chinese Journal of Cancer Research2016，28，3： | 8 |
| 6 | 4-1BB (CD137) Ligand Enhanced Anti-Tumor Immune Response against Mouse Forestomach Carcinoma In Vivo显示文摘Cancer occurrence and development has been demonstrated to be associated with escape from immune surveillance, and low costimulatory molecules expression has been considered as one of the important reasons for cancer evading the immune system. 4-1BB (CD137) is a costimulatory molecule expressed on the surface of activated T cells. Interaction of 4-1BB with its natural ligand (4-1BBL) expressed on antigen presenting cells (APCs) has been shown to amplify T-cell mediated immunity. We therefore examined whether murine cancer cells expressing 4-1BBL could produce anti-tumor effects in inoculated mice. Mouse forestomach carcinoma (MFC) cells were transfected with 4-1BBL gene (MFC/4-1BBL). The proliferation of the transduced cells in vitro was not different from that of parental cells. However, MFC/4-1BBL cells developed small tumors and induced higher cytotoxicity of tumor infiltration lymphocyte (TIL). Production of cytokines (IFN-γ, TNF-α and IL-2) in serum and cytotoxic T lymphocyte (CTL) activity of splenocytes from mice immunized with mitomycin C (MMC)-treated MFC/4-1BBL cells were significantly higher than that from mice immunized with MMC-treated parental MFC and MFC/ pMKITneo cells. These results suggest that modification of cancer cells with 4-1BBL gene can produce anti-tumor immune responses. | Qiaoxia Li Jun Ai Zhenchuan Song Jie Liu Baoen Shan | 2008 | Cellular & Molecular Immunology2008，5，5： | 5 |
| 7 | Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway显示文摘Objective:Small cell lung carcinoma(SCLC)is considered one of the most aggressive types of lung cancer due to its rapid growth and early metastasis.No tumor markers or therapeutic targets have been demonstrated to be specific or effective in SCLC to date.This study aims to evaluate the potential of Flotillin1(Flot1)as a target of SCLC treatment.Methods:Flot1 expression level in the tissue of SCLC and other tissue of lung disease was detected using immunohistochemical staining.Transwell and Matrigel assays were employed to examine migration and invasion of cancer cells.Flow cytometry and xCELLigence system were used to evaluate cell apoptosis and cell viability,respectively.Expression levels of Flot1,epithelialmesenchymal transition(EMT)marker E-cadherin,vimentin,cyclinD1,TGF-β-Smad2/3,and p-AKT were examined using Western blot.Furthermore,xenograft tumor in nude mice was used to evaluate the growth and metastasis of NCI-H446 cells in vivo.Results:Our results demonstrated that Flot1 is highly expressed in SCLC samples and that its expression correlates strongly with clinical stage,distant metastasis,and poor survival.The knockdown of Flot1 decreased the growth,migration,and invasiveness of SCLC cells and reversed EMT phenotype in vitro and in vivo,while enhanced Flot1 expression exhibited the opposite behavior.Gene expression profile analysis demonstrated that Flot1-regulated genes frequently mapped to the AKT and TGF-β-Smad2/3pathways.Our results further revealed that Flot1 affected the progression of SCLC via regulation of EMT progression.Conclusions:These findings indicated an oncogenic role of Flot1 via promoting EMT in SCLC and suggested its potential as a tumor marker and prognostic indicator. | Lianmei Zhao Jie Li Yueping Liu Wei Zhou Yanan Shan Xinyi Fan Xinliang Zhou Baoen Shan Yongmei Song Qimin Zhan | 2018 | Cancer Biology & Medicine2018，15，4： | 3 |
| 8 | Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study显示文摘 | Yishui Lian Meixiang Sang Chunyan Ding Xinliang Zhou Xiaojie Fan Yingying Xu Weihua Lü Baoen Shan | 2012 | Journal of Cancer Research and Clinical Oncology2012，，： | 2 |
| 9 | MAGE-A family: Attractive targets for cancer immunotherapy显示文摘 | Meixiang Sang Yishui Lian Xinliang Zhou Baoen Shan | 2011 | Vaccine2011，，： | 2 |
| 10 | The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression显示文摘 | Xinliang Zhou Yudong Wang Baoen Shan Jing Han Haifeng Zhu Yalei Lv Xiaojie Fan Meixiang Sang Xian-De Liu Wei Liu | 2015 | Medical Oncology2015，，1： | 2 |
| 11 | Ex Vivo Stimulation of Tumor-Draining Lymph Node Cells from Lung Cancer Patients:A Potential Resource for Adoptive Immunotherapy显示文摘To find a feasible method for the stimulation of tumor-draining lymph node (TDLN) cells in preparation for use in the clinic,the CTL activity of TDLN cells induced by different stimuli (IL-2 alone,IL-2 + autologous tumor antigen (atAg),IL-2 + GM-CSF + IL-4 + atAg) was measured by maximal LDH enzyme release. The mechanisms were explored by the observation of morphology and the detection of CD83+ TDLN cells. The expansion of TDLN cells by IL-2 + GM-CSF + IL-4 + atAg was significantly higher than that by IL-2 alone or IL-2 + atAg (p < 0.01). Antitumor CTL activity of TDLN cells induced by IL-2 + GM-CSF + IL-4 + atAg was significantly higher than those of other groups. The number of CD83+ cells within the TDLN population treated with IL-2 + GM-CSF + IL-4 + atAg was significantly elevated. The method of stimulating TDLN cells by IL-2 + GM-CSF + IL-4 + atAg was better than the stimulation with IL-2 or IL-2 + atAg. TDLN cells induced by IL-2 + GM-CSF + IL-4 + atAg produced more dendritic cells (DCs). In our study,we established a system that T cells and DCs were stimulated together ex vivo,which was easy to conduct and produce promising results. It provided a new method for improving TDLN cell antitumor activity which might be used in the clinical cancer therapy. | Baoen Shan Qiliang Li Ming He Yutong He | 2008 | Cellular & Molecular Immunology2008，5，4： | 2 |
| 12 | MAGE-A family: Attractive targets for cancer immunotherapy显示文摘 | Meixiang Sang Yishui Lian Xinliang Zhou Baoen Shan | 2011 | Vaccine2011，，47： | 1 |
| 13 | Melanoma-associated antigen genes – An update显示文摘 | Meixiang Sang Lifang Wang Chunyan Ding Xinliang Zhou Bin Wang Ling Wang Yishui Lian Baoen Shan | 2010 | Cancer Letters2010，，： | 1 |
| 14 | Effects on apoptosis and cell cycle arrest contribute to the antitumorresponses of interleukin-27 mediated by retrovirus in human pancreatic carcinomacells显示文摘 | Lihua Liu Jun Meng Cong Zhang Yuqing Duan Lianmei Zhao Shijie Wang Baoen Shan | 2012 | Oncology Reports2012，，5： | 1 |
| 15 | Antitumor effects and immunoregulation mechanisms of IL-23 gene in mouse mam- mary cancer mediated by retrovirus显示文摘 | Liu Lihua Shan Baoen Feng Yonglu | 2009 | Cellular Immunology2009，258，： | 1 |
| 16 | The expression and clinical significance of melanoma?associated antigen?A1,?A3 and ?A11 in glioma显示文摘 | Liru Guo Meixiang Sang Qingrui Liu Xiaojie Fan Xiao Zhang Baoen Shan | 2013 | Oncology Letters2013，，： | 1 |
| 17 | LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53显示文摘 | Xinliang Zhou Meixiang Sang Wei Liu Wei Gao Enhong Xing Weihua Lü Yingying Xu Xiaojie Fan Shaowu Jing Baoen Shan | 2012 | Life Sciences . 2012 (9-10)2012，，： | 1 |
| 18 | A positive family history of esophageal/gastric cardia cancer with gastric cardia adenocarcinoma is associated with a younger age at onset and more likely with another synchronous esophageal/gastric cardia cancer in a Chinese high-risk area显示文摘 | Denggui Wen Baoen Shan Shijie Wang Liwei Zhang Lizhen Wei Wendi Zhou Qing Peng | 2010 | European Journal of Medical Genetics2010，，5： | 1 |
| 19 | Quercetin inhibit human SW480 colon cancer growth in associationwith inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway显示文摘 | SHAN Baoen WANG Mingxia LI Runqing | 2009 | Cancer Invest2009，27，6： | 1 |
| 20 | CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer显示文摘 | Haixia Ding Lianmei Zhao Suli Dai Lei Li Fujun Wang Baoen Shan | 2016 | Biomedicine & Pharmacotherapy2016，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员